Macular edema
Clinical trials for Macular edema explained in plain language.
Never miss a new study
Get alerted when new Macular edema trials appear
Sign up with your email to follow new studies for Macular edema, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug aims to restore vision in Diabetes-Related swelling
Disease control Recruiting nowThis phase 3 trial tests whether an experimental drug called MK-8748 can treat diabetic macular edema (DME), a condition where fluid builds up in the retina and blurs vision. About 960 adults with DME will receive either MK-8748 or the standard treatment aflibercept via eye injec…
Matched conditions: MACULAR EDEMA
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New Non-Steroid eye shot could ease blurry vision
Disease control Recruiting nowThis study tests a new eye injection called KIO-104 for people with macular edema, a condition where fluid builds up in the eye and blurs vision. About 28 adults will receive multiple doses to see if the drug is safe and helps reduce swelling. The goal is to find a steroid-free o…
Matched conditions: MACULAR EDEMA
Phase 2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a daily pill replace eye injections for diabetic macular edema?
Disease control Recruiting nowThis study tests an oral medication called BI 1815368 in 300 adults with center-involved diabetic macular edema, a common cause of vision loss in diabetes. Participants take tablets twice daily for about 11 months, and doctors compare vision changes between those on the drug and …
Matched conditions: MACULAR EDEMA
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New pill could replace eye injections for Diabetes-Related vision loss
Disease control Recruiting nowThis early-stage trial tests an oral drug called MS-553 in 45 people with diabetic macular edema, a condition that causes vision loss in people with diabetes. Participants take the drug daily for 8 weeks. The main goal is to check safety, but researchers will also measure changes…
Matched conditions: MACULAR EDEMA
Phase 1 • Sponsor: Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Super-Scope for eyes: imaging trial spots hidden clues in blindness
Knowledge-focused Recruiting nowThis study tests a high-resolution imaging system to see tiny structures in the eye that routine tools cannot detect. Researchers will scan 1,200 people with various eye conditions and healthy volunteers. The goal is to better understand diseases like glaucoma, diabetes, and reti…
Matched conditions: MACULAR EDEMA
Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC